Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20436)

• Formulation Name: Spironolactone 50 mg tablet
• Company: G.D. Searle LLC Division of Pfizer Inc

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Spironolactone	(DM2AQ5N)	Chronic heart failure	BD1Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Calcium sulfate dihydrate	(E00315)	24928	Desiccant; Diluent
Eisenoxyd	(E00585)	56841934	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 400	(E00653)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent